xylometazoline |
Special Price
$15.68
Regular Price
$23.00
In stock
SKU
BID464330
Description
Colorless transparent solution.
Colorless transparent solution.
Description
Colorless transparent solution.
Latin name
Snup
Release form
Nasal Spray 0.05%
Packing
Bottle of 15 ml.
Pharmacological action
Xylometazoline belongs to the group of local vasoconstrictors (decongestants) with alpha-adrenomimetic activity, causes narrowing of the blood vessels of the nasal mucosa, eliminating edema and hyperemia of the nasal mucosa, restores patency of the nasal passages, facilitates nasal breathing. The action of the drug occurs 5-10 minutes after its use and lasts up to 12 hours.
Indications
Acute respiratory infections with rhinitis (runny nose), acute allergic rhinitis, hay fever, sinusitis, eustachitis, otitis media (to reduce swelling of the nasopharyngeal mucosa), to facilitate rhinoscopy and other diagnostic procedures in the nasal passages.
Contraindications
Acute respiratory infections with rhinitis (runny nose), acute allergic rhinitis, hay fever, sinusitis, eustachitis, otitis media (to reduce swelling of the nasopharynx), to facilitate rhinoscopy and other diagnostic procedures in the nasal passages.
Composition of
1 ml of nasal spray contains:
active ingredient - xylometazoline hydrochloride 0.5 mg or 1.0 mg and excipients - sea water - 250.0 mg, potassium dihydrogen phosphate - 0.45 mg, purified water - 754, 35 mg or 753.85 mg.
Theoretical total weight - 1005.3 mg.
Dosage and Administration
Intranasally. Snoop® nasal spray 0.05% For children aged 2 to 6 years, 1 injection into each nostril (if necessary, repeat), up to three times a day. Adults and children from 6 years of age, 2 injections in each nostril, up to three times a day. The drug should not be used more often 3 times a day, the duration of the course is not more than 7 days. Before use, it is necessary to clean the nasal passages. Remove the protective cap. Before the first use, press the bezel of the spray nozzle several times until a uniform cloud of “fog” appears. The bottle with the drug is ready for further use. When applying, insert the nozzle into the nasal cavity and press once on the rim. Keep the bottle upright. Do not spray horizontally or down. Immediately after the injection, a light nose inhalation is recommended. After use, close the vial with a protective cap. Each vial must be used individually. After completion of therapy, the drug can be re-prescribed only after a few days. Concerning the duration of use in children should consult a doctor. In case of chronic rhinitis, Snoop® 0.05% and 0.1% can only be used under medical supervision, given the risk of atrophy of the nasal mucosa. If there is no improvement after treatment, or the symptoms worsen, or new symptoms appear, you should consult your doctor. Use the drug only according to the indications, the method of use and at the doses indicated in the instructions.
Side effects
Classification of the frequency of adverse reactions: very often (> 1/10) often (> 1/100 to <1/10) infrequently (> 1/1000 to <1/100) rarely (> 1/10 000 up to <1/1000) is very rare (<1/10000). On the part of the immune system: Very rarely: hypersensitivity reactions (angioedema, rash, itching). From the nervous system: Often: headache. Rarely: insomnia, depression (with prolonged use in high doses). Very rarely: restlessness, fatigue, paresthesia, hallucinations and cramps (mainly in children). From the sensory organs: Very rarely: violation of the clarity of visual perception. On the part of the cardiovascular system: Rarely: palpitations, increased blood pressure. Very rarely: tachycardia, arrhythmia. From the respiratory system: Often: irritation and / or dryness of the nasal mucosa, burning, tingling, sneezing, hypersecretion of the nasopharyngeal mucosa. Rarely: after the use of the drug, an increase in swelling of the nasal mucosa (reactive hyperemia), nosebleed can be observed. From the digestive system: Often: nausea. Rarely: vomiting. Local reactions: Often: burning sensation at the site of use. If you have side effects indicated in the instructions or are aggravated, or you notice any other side effects not listed in the instructions, notify your doctor.
Drug Interactions srdlk Simultaneous use of xylometazoline with monoamine oxidase inhibitors, tricyclic and tetracyclic antiperspirants, other localities contraindicated. If you use the above or other medicines (including OTC medicines), consult your doctor before using Snoop®.
overdose
Symptoms: In the case of drug overdose, the clinical picture is an alternation of the excitation phases of the central nervous system (anxiety, excitation, hallucinations, convulsions) with phases of depression of the central nervous system (decrease in body temperature, lethargy, drowsiness, coma). The following symptoms may also occur: miosis, mydriasis, increased sweating, fever, pallor, cyanosis, nausea and vomiting, tachycardia, bradycardia, cardiac arrhythmias, cardiac arrest, palpitations, increased blood pressure, decreased blood pressure, pulmonary artery pressure. , respiratory depression and apnea, psychogenic disorders.
In children, an overdose with dominant central effects with convulsions, coma and bradycardia, apnea, and an increase in blood pressure, followed by hypotension.
Treatment: Symptomatic, under the supervision of a doctor.
In case of accidental administration of the drug inside - the introduction of activated carbon, gastric lavage.
In case of severe overdose, intensive care is shown in the hospital. In serious cases, non-selective alpha-blockers can be used to lower blood pressure, antipyretics, intubation, and artificial lung ventilation.
Storage conditions
At a temperature not exceeding 25 РC. After opening the bottle, the drug should be used within 12 months. Keep out of the reach of children.
Expiration
5 years. The contents of the vial are sterile, without preservatives. Do not use after the expiry date. If the medicine has expired, do not dispose of it in waste water or outdoors! Put the medicine in the trash can. These measures will help to protect the environment.
Deystvuyuschee substances
xylometazoline
Sardlkp pharmacy terms and conditions Over-the-counter
Dosage form
Dosage form
nasal spray
Ursafarm Arzneimittel, Germany
Colorless transparent solution.
Latin name
Snup
Release form
Nasal Spray 0.05%
Packing
Bottle of 15 ml.
Pharmacological action
Xylometazoline belongs to the group of local vasoconstrictors (decongestants) with alpha-adrenomimetic activity, causes narrowing of the blood vessels of the nasal mucosa, eliminating edema and hyperemia of the nasal mucosa, restores patency of the nasal passages, facilitates nasal breathing. The action of the drug occurs 5-10 minutes after its use and lasts up to 12 hours.
Indications
Acute respiratory infections with rhinitis (runny nose), acute allergic rhinitis, hay fever, sinusitis, eustachitis, otitis media (to reduce swelling of the nasopharyngeal mucosa), to facilitate rhinoscopy and other diagnostic procedures in the nasal passages.
Contraindications
Acute respiratory infections with rhinitis (runny nose), acute allergic rhinitis, hay fever, sinusitis, eustachitis, otitis media (to reduce swelling of the nasopharynx), to facilitate rhinoscopy and other diagnostic procedures in the nasal passages.
Composition of
1 ml of nasal spray contains:
active ingredient - xylometazoline hydrochloride 0.5 mg or 1.0 mg and excipients - sea water - 250.0 mg, potassium dihydrogen phosphate - 0.45 mg, purified water - 754, 35 mg or 753.85 mg.
Theoretical total weight - 1005.3 mg.
Dosage and Administration
Intranasally. Snoop® nasal spray 0.05% For children aged 2 to 6 years, 1 injection into each nostril (if necessary, repeat), up to three times a day. Adults and children from 6 years of age, 2 injections in each nostril, up to three times a day. The drug should not be used more often 3 times a day, the duration of the course is not more than 7 days. Before use, it is necessary to clean the nasal passages. Remove the protective cap. Before the first use, press the bezel of the spray nozzle several times until a uniform cloud of “fog” appears. The bottle with the drug is ready for further use. When applying, insert the nozzle into the nasal cavity and press once on the rim. Keep the bottle upright. Do not spray horizontally or down. Immediately after the injection, a light nose inhalation is recommended. After use, close the vial with a protective cap. Each vial must be used individually. After completion of therapy, the drug can be re-prescribed only after a few days. Concerning the duration of use in children should consult a doctor. In case of chronic rhinitis, Snoop® 0.05% and 0.1% can only be used under medical supervision, given the risk of atrophy of the nasal mucosa. If there is no improvement after treatment, or the symptoms worsen, or new symptoms appear, you should consult your doctor. Use the drug only according to the indications, the method of use and at the doses indicated in the instructions.
Side effects
Classification of the frequency of adverse reactions: very often (> 1/10) often (> 1/100 to <1/10) infrequently (> 1/1000 to <1/100) rarely (> 1/10 000 up to <1/1000) is very rare (<1/10000). On the part of the immune system: Very rarely: hypersensitivity reactions (angioedema, rash, itching). From the nervous system: Often: headache. Rarely: insomnia, depression (with prolonged use in high doses). Very rarely: restlessness, fatigue, paresthesia, hallucinations and cramps (mainly in children). From the sensory organs: Very rarely: violation of the clarity of visual perception. On the part of the cardiovascular system: Rarely: palpitations, increased blood pressure. Very rarely: tachycardia, arrhythmia. From the respiratory system: Often: irritation and / or dryness of the nasal mucosa, burning, tingling, sneezing, hypersecretion of the nasopharyngeal mucosa. Rarely: after the use of the drug, an increase in swelling of the nasal mucosa (reactive hyperemia), nosebleed can be observed. From the digestive system: Often: nausea. Rarely: vomiting. Local reactions: Often: burning sensation at the site of use. If you have side effects indicated in the instructions or are aggravated, or you notice any other side effects not listed in the instructions, notify your doctor.
Drug Interactions srdlk Simultaneous use of xylometazoline with monoamine oxidase inhibitors, tricyclic and tetracyclic antiperspirants, other localities contraindicated. If you use the above or other medicines (including OTC medicines), consult your doctor before using Snoop®.
overdose
Symptoms: In the case of drug overdose, the clinical picture is an alternation of the excitation phases of the central nervous system (anxiety, excitation, hallucinations, convulsions) with phases of depression of the central nervous system (decrease in body temperature, lethargy, drowsiness, coma). The following symptoms may also occur: miosis, mydriasis, increased sweating, fever, pallor, cyanosis, nausea and vomiting, tachycardia, bradycardia, cardiac arrhythmias, cardiac arrest, palpitations, increased blood pressure, decreased blood pressure, pulmonary artery pressure. , respiratory depression and apnea, psychogenic disorders.
In children, an overdose with dominant central effects with convulsions, coma and bradycardia, apnea, and an increase in blood pressure, followed by hypotension.
Treatment: Symptomatic, under the supervision of a doctor.
In case of accidental administration of the drug inside - the introduction of activated carbon, gastric lavage.
In case of severe overdose, intensive care is shown in the hospital. In serious cases, non-selective alpha-blockers can be used to lower blood pressure, antipyretics, intubation, and artificial lung ventilation.
Storage conditions
At a temperature not exceeding 25 РC. After opening the bottle, the drug should be used within 12 months. Keep out of the reach of children.
Expiration
5 years. The contents of the vial are sterile, without preservatives. Do not use after the expiry date. If the medicine has expired, do not dispose of it in waste water or outdoors! Put the medicine in the trash can. These measures will help to protect the environment.
Deystvuyuschee substances
xylometazoline
Sardlkp pharmacy terms and conditions Over-the-counter
Dosage form
Dosage form
nasal spray
Ursafarm Arzneimittel, Germany
Write Your Own Review